Table 3.

Clinical characteristics of participants in study

Variable	Total sample (n=107)	Did not come to clinic (n=90)	Came to clinic (n=17)	p-value*
Type of cancer				0.992
Bladder	44 (41%)	37 (84%)	7 (16%)
Uterine	15 (14%)	13 (87%)	2 (13%)
Ovarian	14 (13%)	12 (86%)	2 (14%)
Cervical	12 (11%)	9 (75%)	3 (25%)
Endometrial	12 (11%)	10 (83%)	2 (17%)
Testicular	4 (4%)	3 (75%)	1 (25%)
Colon	2 (2%)	2 (100%)	0 (0%)
Kidney	1 (1%)	2 (100%)	0 (0%)
Other sites	3 (3%)	3 (100%)	0 (0%)
Lymph nodes removed				0.85
Yes	30 (29%)	24 (28%)	6 (35%)
No	54 (53%)	45 (53%)	9 (53%)
Not sure	18 (18%)	16 (19%)	2 (12%)
Radiation treatment				0.16
Yes	38 (37%)	29 (35%)	9 (53%)
No	63 (62%)	54 (64%)	8 (47%)
Not sure	1 (1%)	1 (1%)	0 (0%)
Have you ever heard about lymphedema				0.25
Yes	23 (23%)	16 (19%)	7 (41%)
No	74 (73%)	64 (75%)	10 (59%)
Not sure	5 (5%)	5 (6%)	0 (0%)
Ever been told you have lymphedema				0.02
Yes	6 (6%)	2 (2%)	4 (24%)
No	90 (90%)	78 (93%)	12 (71%)
Not sure	5 (4%)	4 (5%)	1 (6%)
Received treatment for lymphedema				0.18
Yes	7 (7%)	3 (4%)	4 (24%)
No	89 (87%)	76 (89%)	13 (76%)
Not sure	6 (5%)	6 (7%)	0 (0%)
Median [IQR] lymphedema symptoms	0 [0–4]	0 [0–3]	4 [3–9.5]	0.004

Results are No. (%) or median [IQR] where noted.

^*examining differences between those that came to clinic versus did-not using Fishers exact and rank-sum test. May not sum to 100% due to rounding error and non-item response.